Menopause. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: first intervention group: One CimiFugol coated tablet containing 6.5 mg of dry root of black cohosh plant manufactured by GolDaru Company will be taken daily for 8 weeks every night at
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Obtaining a score of 5 and above from the MRS questionnaire 12 months or more have passed since menopause Age between 45 and 65 years
Exclusion criteria
Exclusion criteria: Presence or history of breast and uterine cancer, abnormal vaginal bleeding, liver, kidney, thyroid, depression and known anxiety disorders. Use of progestins, contraceptive pills, GNRH agonists and antagonists Taking drugs that interact with the studied drugs, such as warfarin, tamoxifen, antipsychotics, and dopamine antagonists.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of menopausal symptoms. Timepoint: The total score of menopausal symptoms is checked at the beginning of the study (before the start of the intervention), the fourth and the eighth week after the start of the intervention. Method of measurement: Menopause Rating Scale (MRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMansour Siavash
Esfahan University of Medical Sciences
Outcome results
None listed